In Response

Affiliations

¹ Johns Hopkins Center for Injury Research and Policy, Johns Hopkins Bloomberg School of Public, Health, Baltimore, MD.
² R Adams Cowley Shock Trauma Center, Division of Infectious Disease, University of Maryland School of Medicine, Baltimore, MD.
³ R Adams Cowley Shock Trauma Center, Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD.

Comment

Anthony R Carlini et al. J Orthop Trauma. 2021.

. 2021 Nov 1;35(11):e437-e438.

doi: 10.1097/BOT.0000000000002223.

¹ Johns Hopkins Center for Injury Research and Policy, Johns Hopkins Bloomberg School of Public, Health, Baltimore, MD.
² R Adams Cowley Shock Trauma Center, Division of Infectious Disease, University of Maryland School of Medicine, Baltimore, MD.
³ R Adams Cowley Shock Trauma Center, Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD.

No abstract available

Conflict of interest statement

The authors report no conflict of interest.

Vancomycin Powder Use in Fractures at High Risk of Surgical Site Infection.
Qadir R, Costales T, Coale M, Mulliken A, Zerhusen T Jr, Joshi M, Castillo RC, Carlini AR, O'Toole RV. Qadir R, et al. J Orthop Trauma. 2021 Jan 1;35(1):23-28. doi: 10.1097/BOT.0000000000001863. J Orthop Trauma. 2021. PMID: 32898082
Letter to the Editor on "Vancomycin Powder Use in Fractures at High Risk of Surgical Site Infection".
Lou X, Zhao WM, Zhang Y. Lou X, et al. J Orthop Trauma. 2021 Nov 1;35(11):e437. doi: 10.1097/BOT.0000000000002222. J Orthop Trauma. 2021. PMID: 34653109 No abstract available.

1. Qadir R, Costales T, Coale M, et al. Vancomycin powder use in fractures at high risk of surgical site infection. J Orthop Trauma. 2021;35:23–28.
1. Stafford RS. Regulating off-label drug use—rethinking the role of the FDA. N Engl J Med. 2008;358:1427–1429.
1. OʼToole RV, Joshi M, Carlini AR, et al. Local antibiotic therapy to reduce infection after operative treatment of fractures at high risk of infection: a multicenter, randomized, controlled trial (VANCO study). J Orthop Trauma. 2017;31:S18–S24.
1. Major Extremity Trauma Research Consortium (METRC). Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial. JAMA Surg.2021:e207259.
1. Qadir R, Costales T, Coale M, et al. Topical vancomycin powder decreases the proportion of Staphylococcus aureus found in culture of surgical site infections in operatively treated fractures. J Orthop Trauma. 2021;35:17–22.